Incyte Corporation

Financials

Activos totales 3.56 B4.93 B5.84 B6.78 B5.44 B6.96 B Total de pasivos 949.65 M1.16 B1.47 B1.59 B2 B1.79 B Capital total 2.61 B3.77 B4.37 B5.19 B3.45 B5.17 B Total de pasivos y patrimonio neto 3.56 B4.93 B5.84 B6.78 B5.44 B6.96 B Deuda total —————— Deuda neta ——————

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

INCY

Financials

Incyte Corporation

Noticias

Leaderboard Trimmed, But Cloudflare, Caterpillar Among 5 Stocks To Watch

Citizens reitera calificación de acciones de Incyte por avances en pipeline

Susanne Schaffert dejará la junta directiva de Incyte en abril

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study

William Blair reitera calificación Market Perform en Incyte tras datos de HS

KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data

UBS reduce el precio objetivo de Incyte por preocupaciones sobre ingresos a 94 dólares

Incyte anuncia cambios en la dirección ejecutiva e integra equipos de EE.UU.

H.C. Wainwright reitera calificación de Incyte citando potencial del fármaco oral

Barclays reitera calificación de acciones de Incyte tras resultados mixtos del ensayo

Undercovered Stocks: Rayonier, Tower Semiconductor, British American Tobacco And More

Incyte: An Undervalued Healthcare Gem (NASDAQ:INCY)